Charles S. Mayo, PhD

Re-irradiation is increasingly used for patients with local recurrence or new tumors adjacent to a previously irradiated site. However, high-level evidence on re-irradiation is scarce, particularly the safety and toxicity from cumulative dose. Moreover, there...

For a new course of liver stereotactic body radiation (reirradiation), we apply a normal tissue complication probability(NTCP) model to guide planning and estimate toxicity risk. We assessed the effectiveness of this approach in achieving longer survival and...

Professional